Emerging Information
October 19, 2011: Insight Pharmaceuticals, LLC of Langhorne, Pa., is recalling one lot (34,092 bottles) of Nostrilla Nasal Decongestant nasal spray to the consumer level, because it may contain the bacteria Burkholderia cepacia.
Burkholderia cepacia may cause serious infection in individuals with a compromised immune system or chronic lung condition (i.e. cystic fibrosis). However, the possibility of infection is remote in healthy individuals.
Nostrilla Nasal Decongestant, lot #11G075, UPC Code 6373673005, was distributed nationwide through normal retail outlets and pharmacies. The product comes in a 1/2 ounce, plastic bottle marked with lot #11G075 on the label and with an expiration date of 05/2014 stamped on the side. No illnesses have been reported to date in connection with this problem.
The recall was initiated following internal investigations which determined the potential presence of a microbial contaminant that exceeds the product specifications and may consequently result in a subpar product. This contaminant has been found sporadically throughout only the respective manufacturing lot, #11G075.
Insight Pharmaceuticals recommends the following:
Consumers who have purchased "Nostrilla Decongestant, lot #11G075" are urged to return the product and contact the company at 1-877-546-9059 Monday through Friday from 9 am-5 pm EST time zone.
Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
October 3, 2011: Superior Metabolic Technologies Inc of Marietta, Georgia is voluntarily recalling all lots of the testosterone booster Uprizing 2.0 because tests have shown the product appears to contain superdrol, a synthetic steroid, making it an unapproved new drug.
On August 5 the FDA made Superior Metabolic Technologies Inc aware that Uprizing 2.0 contains superdrol which is banned by the FDA. This led to the recall of the product.
Acute liver injury is known to be a possible harmful effect of using products containing synthetic anabolic steroids. In addition, use of synthetic anabolic steroids may cause other serious long-term adverse health consequences in men, women, and children. These include shrinkage of the testes and male infertility, masculinization of women, breast enlargement in males, short stature in children, a higher prediction to misuse other drugs and alcohol, adverse effects on blood lipid levels, and increased risk of heart attack, stroke, and death.
Uprizing 2.0 was distributed through retail health food stores in Alabama, Arizona, California, Georgia, Mississippi, New Jersey, South Carolina, and Texas.
Uprizing 2.0 comes in a black plastic bottle with a black, red, and silver label and contains 90 capsules. The SMT logo is center top on the bottle.
Superior Metabolic Technologies Inc recommends the following:
- Consumers who purchased Uprizing 2.0 are urged to return it to the place of purchase for a full refund.
- Consumers with questions may contact the company at 1-888-445-3230, from 10 AM to 6 PM EST Monday through Friday.
